Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2024-08-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
113年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple dates within the fiscal year 2024, specifically for the second quarter ending June 30, 2024, and comparative data from previous periods. The presence of actual financial figures such as assets, liabilities, and equity indicates this is a substantive financial report rather than a brief announcement or certification. The document length is 4019 characters, which is relatively short but contains detailed financial statements. Given the content and the period covered (quarterly data), this aligns with an Interim / Quarterly Report (IR) rather than an Annual Report or Earnings Release. There is no indication that this is merely an announcement or a certification, so it should be classified as an Interim / Quarterly Report.
2024-08-13 Chinese
公告本公司董事會通過113年第二季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1760 寶齡富錦) reporting the board's approval of the consolidated financial report for the second quarter of the year 113 (Taiwan calendar, equivalent to 2024). It includes cumulative financial data from January 1 to June 30, such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document is short (908 characters) and primarily serves as a formal announcement of the board's approval of the interim financial report rather than the full report itself. It does not contain detailed financial statements or extensive analysis but summarizes key financial figures. Therefore, it fits the category of an Interim / Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year and is not merely an announcement of report publication or a certification. Confidence is high due to the presence of detailed financial figures and the reporting period specified.
2024-08-13 Chinese
113年07月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a report publication, earnings release, or regulatory certification. The document is not a proxy statement or voting result announcement. Given the detailed insider shareholding data, this fits the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives.
2024-08-09 Chinese
113年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, independent directors, general manager, and other executives. It focuses on insider shareholdings and pledges, with no financial statements or earnings data. The content is about personal share transactions or holdings by company directors and executives. The document length is 3187 characters, which is relatively short but contains detailed insider shareholding data. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. There is no indication of it being an announcement of a report or a certification, so it is not RNS or RPA. Therefore, the correct classification is DIRS with high confidence.
2024-08-09 Chinese
113年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company, providing details about fund lending balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (613 characters) and does not include comprehensive financial statements or analysis. It appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a report. There is no indication of an annual or interim report, earnings release, or other specific report types. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2024-08-08 Chinese
113年7月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 寶齡富錦, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or audit information. The length is short (773 characters), and it is essentially a revenue summary update. There is no indication that this is a full annual or interim report, nor is it an announcement of a meeting or voting results. It is a brief financial data summary, which aligns best with a Fund Information / Factsheet (FS) type, as it provides key financial facts in a concise manner.
2024-08-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.